amlodipine has been researched along with Peripheral Arterial Disease in 1 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
Peripheral Arterial Disease: Lack of perfusion in the EXTREMITIES resulting from atherosclerosis. It is characterized by INTERMITTENT CLAUDICATION, and an ANKLE BRACHIAL INDEX of 0.9 or less.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypertension is a major risk factor for peripheral artery disease (PAD)." | 2.79 | Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT. ( Baraniuk, S; Basile, JN; Dart, RA; Davis, BR; Ellsworth, AJ; Fendley, H; Habib, GB; Piller, LB; Probstfield, JL; Rahman, M; Simpson, LM; Whelton, PK, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Piller, LB | 1 |
| Simpson, LM | 1 |
| Baraniuk, S | 1 |
| Habib, GB | 1 |
| Rahman, M | 1 |
| Basile, JN | 1 |
| Dart, RA | 1 |
| Ellsworth, AJ | 1 |
| Fendley, H | 1 |
| Probstfield, JL | 1 |
| Whelton, PK | 1 |
| Davis, BR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00000542] | Phase 3 | 0 participants | Interventional | 1993-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for amlodipine and Peripheral Arterial Disease
| Article | Year |
|---|---|
Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT.
Topics: Aged; Amlodipine; Antihypertensive Agents; Chlorthalidone; Double-Blind Method; Female; Follow-Up St | 2014 |